9 research outputs found
NUOVI AGENTI TERAPEUTICI PER IL TRATTAMENTO DI PATOLOGIE EMATOLOGICHE
La presente invenzione si riferisce al campo di nuove molecole tetracicliche, aventi
un sistema tetraciclico, e loro impiego come medicamenti di patologie ematologiche
in particolare per il trattamento della leucemia mieloide acuta (AML) in pazienti
emizigoti FLT3/ITD resistenti alle terapie convenzionali
Synthesis of substituted carbamo(dithioperoxo)thioates as potential BCA2-inhibitory anticancer agents
A new, simple, one-step synthetic route to carbamo(dithioperoxo)thioates from commercially available starting materials is described. The key step of this new synthetic approach involves the tetrabromomethane-promoted reaction between secondary amines, carbon disulfide and alkyl thiols under basic conditions at room temperature. New compounds from this series selected for anticancer screening showed selective sub-micromolar activity within BCA2-expressing human breast cancer cell lines
Evaluation of Fused Pyrrolothiazole Systems as Correctors of Mutant CFTR Protein
Cystic fibrosis (CF) is a genetic disease caused by mutations that impair the function of the CFTR chloride channel. The most frequent mutation, F508del, causes misfolding and premature degradation of CFTR protein. This defect can be overcome with pharmacological agents named “correctors”. So far, at least three different classes of correctors have been identified based on the additive/synergistic effects that are obtained when compounds of different classes are combined together. The development of class 2 correctors has lagged behind that of compounds belonging to the other classes. It was shown that the efficacy of the prototypical class 2 corrector, the bithiazole corr-4a, could be improved by generating conformationally-locked bithiazoles. In the present study, we investigated the effect of tricyclic pyrrolothiazoles as analogues of constrained bithiazoles. Thirty-five compounds were tested using the functional assay based on the halide-sensitive yellow fluorescent protein (HS-YFP) that measured CFTR activity. One compound, having a six atom carbocyle central ring in the tricyclic pyrrolothiazole system and bearing a pivalamide group at the thiazole moiety and a 5-chloro-2-methoxyphenyl carboxamide at the pyrrole ring, significantly increased F508del-CFTR activity. This compound could lead to the synthesis of a novel class of CFTR correctors
Preclinical Activity of New [1,2]Oxazolo[5,4-e]isoindole Derivatives in Diffuse Malignant Peritoneal Mesothelioma
A series of 22 derivatives of the [1,2]oxazolo[5,4-e]isoindole system were synthesized through an efficient and versatile procedure that involves the annelation of the [1,2]oxazole moiety to the isoindole ring, producing derivatives with a wide substitution pattern. The structure-activity relationship indicates that the N-4-methoxybenzyl group appears crucial for potent activity. In addition, the presence of a 6-phenyl moiety is important and the best activity is reached with a 3,4,5-trimethoxy substituent. The most active compound, bearing both the structural features, was able to inhibit tumor cell proliferation at nanomolar concentrations when tested against the full NCI human tumor cell line panel. Interestingly, this compound was effective in reducing in vitro and in vivo cell growth, impairing cell cycle progression and inducing apoptosis, as a consequence of the inhibition of tubulin polymerization, in experimental models of diffuse malignant peritoneal mesothelioma (DMPM), a rapidly lethal disease, poorly responsive to conventional therapeutic strategies
Pyrrolo[3\u2032,2\u2032:6,7]cyclohepta[1,2-b]pyridines with potent photo-antiproliferative activity
Pyrrolo[3\u2032,2\u2032:6,7]cyclohepta[1,2-b]pyridines were synthesized as a new class of tricyclic system in which the pyridine ring is annelated to a cycloheptapyrrole scaffold, with the aim of obtaining new photosensitizing agents with improved antiproliferative activity and lower undesired toxic effects. A versatile synthetic pathway was approached, which allowed the isolation of derivatives of the title ring system with a good substitution pattern on the pyrrole moiety. Photobiological studies revealed that the majority of the new compounds showed a potent cytotoxic effect upon photoactivation with light of the proper wavelength, especially when decorated with a 2-ethoxycabonyl group and a N-benzyl substituted moiety, with EC50values reaching the submicromolar level. The mechanism of action was evaluated
Preclinical Activity of New [1,2]Oxazolo[5,4‑<i>e</i>]isoindole Derivatives in Diffuse Malignant Peritoneal Mesothelioma
A series of 22 derivatives
of the [1,2]ÂoxazoloÂ[5,4-<i>e</i>]Âisoindole system were synthesized
through an efficient and versatile
procedure that involves the annelation of the [1,2]Âoxazole moiety
to the isoindole ring, producing derivatives with a wide substitution
pattern. The structure–activity relationship indicates that
the <i>N</i>-4-methoxybenzyl group appears crucial for potent
activity. In addition, the presence of a 6-phenyl moiety is important
and the best activity is reached with a 3,4,5-trimethoxy substituent.
The most active compound, bearing both the structural features, was
able to inhibit tumor cell proliferation at nanomolar concentrations
when tested against the full NCI human tumor cell line panel. Interestingly,
this compound was effective in reducing in vitro and in vivo cell
growth, impairing cell cycle progression and inducing apoptosis, as
a consequence of the inhibition of tubulin polymerization, in experimental
models of diffuse malignant peritoneal mesothelioma (DMPM), a rapidly
lethal disease, poorly responsive to conventional therapeutic strategies